Do you discharge patients on preventative therapies like octreotide or bevacizumab after a patient's first admission for symptomatic anemia secondary to bleeding from a small bowel AVM that was treated with APC?
Community PollStarted
Do you discharge patients on preventative therapies like octreotide or bevacizumab after a patient's first admission for symptomatic anemia secondary to bleeding from a small bowel AVM that was treated with APC?
42 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet Member
Gastroenterology · Volchonok Oleg Office
Answered on
Not cost effective
Join for free or sign in to see the full answer